Patent · US Active

Conditional gene vectors regulated in cis

US7803617B2 · kind B2 · utility

5Cited by

0References

23Claims

0Family size

Assignee

Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) · DE

Inventors

Wolfgang Hammerschmidt · Munich, DE
Sibille Humme · Cologne, DE
Dagmar Pich · Munich, DE
Aloys Schepers · Munich, DE

Key dates

Filing date	Feb 13, 2007
Grant date	Sep 28, 2010
Priority date	—
Expiry date	May 15, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/003
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to a conditional gene vector system and to a host cell, which has been transfected with such a vector system. The present invention is further directed to a combined preparation comprising the vector system of the invention and an interfering agent. Furthermore, a pharmaceutical composition and its use in the treatment of hemophilia, diabetes, rheumatoid arthritis, genetic immunodeficiency, and graft versus host disease is provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.